Can I Take Lion's Mane with Amlodipine?

At a glance
- Drug / amlodipine (calcium channel blocker, 2.5 to 10 mg daily)
- Supplement / lion's mane (Hericium erinaceus), typical dose 500 to 3,000 mg/day
- Interaction classification / theoretical; no confirmed clinical case reports as of 2025
- Primary concern 1 / additive hypotension (pharmacodynamic)
- Primary concern 2 / mild antiplatelet effect of H. Erinaceus polysaccharides
- CYP450 risk / low; lion's mane shows minimal CYP3A4 inhibition in vitro
- Monitoring / home BP log for 2 to 4 weeks after starting lion's mane
- Who should avoid without MD approval / patients on anticoagulants, dual antiplatelet therapy, or with SBP habitually <100 mmHg
- Evidence level / preclinical and small human trials only; no randomized controlled trial on this combination
What Is Amlodipine and How Does It Work?
Amlodipine is a dihydropyridine calcium channel blocker approved by the FDA for hypertension and chronic stable or vasospastic angina [1]. It blocks L-type calcium channels in vascular smooth muscle, reducing peripheral vascular resistance and lowering systolic blood pressure by roughly 10 to 15 mmHg at the 10 mg dose in placebo-controlled trials [2].
Pharmacokinetic profile
Amlodipine is metabolized primarily by hepatic CYP3A4, with a half-life of 30 to 50 hours [1]. Because it relies almost entirely on CYP3A4 for clearance, any substance that inhibits or induces this enzyme significantly changes plasma amlodipine levels. Grapefruit juice, for example, inhibits intestinal CYP3A4 and can raise amlodipine exposure by up to 16% [3].
Clinical context
The CAMELOT trial (N=1,991) compared amlodipine 10 mg daily versus placebo in patients with coronary artery disease and demonstrated a 31% reduction in cardiovascular events over 24 months (P<0.001) [4]. That track record makes unnecessary discontinuation of amlodipine genuinely risky. Any supplement added to the regimen therefore needs to be assessed for whether it could blunt or amplify that effect.
What Is Lion's Mane and Why Do People Take It?
Lion's mane is a culinary and medicinal mushroom. The two biologically active compound classes are hericenones (found in the fruiting body) and erinacines (found in the mycelium). Both stimulate nerve growth factor (NGF) synthesis, which is why lion's mane is studied primarily for cognitive support and peripheral neuropathy [5].
Cognitive and neurological research
A double-blind, placebo-controlled trial published in Phytotherapy Research (N=30, age 50 to 80) showed that 3 g/day of H. Erinaceus powder for 16 weeks significantly improved cognitive scores compared to placebo (P<0.001), with scores returning to baseline 4 weeks after stopping [6]. A separate 2023 parallel-group trial (N=41) at the University of Queensland found that a single 1.8 g dose acutely improved processing speed and working memory [7].
Cardiovascular and platelet effects
This is where the interaction with amlodipine becomes relevant. Animal studies show that H. Erinaceus polysaccharides reduce platelet aggregation induced by adenosine diphosphate (ADP) [8]. A 2010 paper in the Journal of Agricultural and Food Chemistry identified specific beta-glucan fractions responsible for this antiplatelet activity, with an IC50 comparable to low-dose aspirin in vitro [8]. Whether these concentrations are achieved at typical oral doses in humans remains unclear, but the concern is not trivial for patients already on antithrombotics.
Does Lion's Mane Interact with Amlodipine? The Two Mechanisms
No published clinical interaction study between lion's mane and amlodipine exists as of early 2025. The concern is theoretical but grounded in distinct mechanisms: one pharmacodynamic and one pharmacokinetic.
Pharmacodynamic concern: additive blood-pressure lowering
Amlodipine lowers blood pressure by reducing vascular tone. Lion's mane may add a secondary vasodilatory push. A rodent study published in Evidence-Based Complementary and Alternative Medicine found that H. Erinaceus extract reduced mean arterial pressure in spontaneously hypertensive rats by approximately 12 mmHg over 4 weeks [9]. The mechanism appears to involve ACE-inhibitory peptides derived from mushroom proteins [9].
If lion's mane produces even a modest 5 to 8 mmHg reduction in humans, and amlodipine is already achieving its full antihypertensive effect, the combined drop could push systolic pressure below 90 mmHg in susceptible individuals. Symptomatic hypotension (dizziness, syncope) is the practical risk. Patients who are already near target or whose systolic pressure runs <110 mmHg on amlodipine alone carry the highest risk.
Pharmacokinetic concern: CYP3A4 inhibition
Amlodipine is a CYP3A4 substrate. If lion's mane inhibits CYP3A4, amlodipine plasma levels could rise, amplifying both its antihypertensive effect and its adverse effects (peripheral edema, reflex tachycardia).
The available in vitro data are reassuring but not definitive. A 2021 screening study published in Molecules tested 14 medicinal mushroom extracts against a CYP enzyme panel; H. Erinaceus ethanol extract showed only weak CYP3A4 inhibition at concentrations far above what standard oral doses achieve [10]. The IC50 for CYP3A4 inhibition was above 200 µg/mL, a concentration unlikely to be reached in portal circulation after typical 500 to 2,000 mg oral doses [10]. This suggests pharmacokinetic interaction is low probability but cannot be excluded without human pharmacokinetic studies.
Antiplatelet Risk: The Overlooked Concern
Amlodipine itself has no clinically significant antiplatelet activity. But patients on amlodipine are often also taking low-dose aspirin (81 mg) or a P2Y12 inhibitor such as clopidogrel after a cardiovascular event. Adding lion's mane polysaccharides on top of existing antiplatelet therapy raises the theoretical bleeding risk.
What the preclinical data show
The beta-glucan fraction of H. Erinaceus inhibited ADP-induced platelet aggregation by approximately 35% in vitro at 1 mg/mL [8]. Thromboxane A2 synthesis was also reduced in the same model, suggesting a mechanism overlapping with aspirin's action [8]. These are cell-culture findings, not human pharmacology data. Still, they justify caution in patients already on dual antiplatelet therapy or warfarin.
Practical risk stratification
Patients taking amlodipine alone (no antiplatelet agent) face minimal bleeding risk from lion's mane at standard doses. Patients on amlodipine plus aspirin face a low but non-zero added risk. Patients on amlodipine, aspirin, and clopidogrel after a recent acute coronary syndrome should not add lion's mane without explicit cardiologist approval.
Is Lion's Mane Safe with Amlodipine? Clinical Guidance
For most people taking amlodipine for uncomplicated hypertension, lion's mane at doses of 500 to 1,000 mg/day is probably safe. The word "probably" is doing real work there: the absence of a documented interaction is not the same as a proven safe interaction.
Monitoring protocol
Start lion's mane at the lowest available dose (500 mg once daily). Check home blood pressure twice daily for the first 2 weeks and log the readings. If systolic BP drops more than 10 mmHg below your average on amlodipine alone, contact your prescriber before continuing. Dizziness on standing (orthostatic hypotension) warrants prompt evaluation.
When to get physician sign-off first
Speak to your prescriber before combining these two if any of the following apply:
- Systolic BP on amlodipine is currently below 120 mmHg
- You are also taking aspirin, clopidogrel, ticagrelor, warfarin, apixaban, or rivaroxaban
- You have aortic stenosis or heart failure with reduced ejection fraction (conditions in which amlodipine is already used cautiously) [2]
- You are scheduled for surgery or a dental procedure within 4 weeks
What the American College of Cardiology says about supplements and antihypertensives
The 2023 ACC/AHA Hypertension Guideline writing committee states: "Patients should be asked at every visit about over-the-counter medications and dietary supplements, as some may interfere with antihypertensive drug efficacy or increase adverse-event risk." [11] Lion's mane falls squarely in this category.
What Conditions Might Make Lion's Mane Beneficial for Amlodipine Users?
People prescribed amlodipine often have metabolic risk factors: insulin resistance, early cognitive decline associated with cardiovascular disease, or diabetic peripheral neuropathy. These are precisely the populations in which lion's mane has the strongest preliminary evidence.
Diabetic neuropathy
A 2015 pilot trial (N=30) in male volunteers with type 2 diabetes and peripheral neuropathy found that 3 g/day of H. Erinaceus for 12 weeks reduced neuropathy symptom scores compared to baseline (P=0.038) and improved nerve conduction velocity in the sural nerve [12]. Given that many amlodipine users have comorbid diabetes, this is a clinically relevant potential benefit.
Cognitive protection in cardiovascular disease
Vascular cognitive impairment is a recognized complication of poorly controlled hypertension [13]. The NGF-stimulating erinacines from lion's mane mycelium could theoretically offer a neuroprotective benefit in this population. The 2023 University of Queensland trial referenced earlier found acute cognitive improvements, though long-term data in cardiovascular patients are absent [7].
How to Take Lion's Mane if You Are on Amlodipine
Dose separation is not strictly necessary based on current pharmacokinetic data, because the CYP3A4 overlap appears minimal. Taking them at different times of day does no harm, however, and reduces the theoretical scenario of peak lion's mane polysaccharide absorption coinciding with peak amlodipine plasma concentration.
Practical dosing schedule
Amlodipine is typically taken once daily, often in the morning. Taking lion's mane in the evening with food is a reasonable approach. Food slows gastric emptying and may reduce peak polysaccharide absorption rate, which could lower the magnitude of any transient BP effect.
Start with 500 mg/day for the first week before titrating to 1,000 mg/day. The cognitive trials that showed benefit used 3,000 mg/day [6], but that dose has not been evaluated alongside antihypertensives. Work up to higher doses only after establishing that lower doses do not affect your blood pressure readings.
Product quality matters
Lion's mane supplements are not FDA-regulated for efficacy, and the polysaccharide content varies considerably between products. A 2017 analysis published in Food Chemistry found that beta-glucan content in commercial lion's mane products ranged from 1.5% to 43.7% of label claims [14]. Choose a product with third-party certification (NSF International, USP, or Informed Sport) to ensure the dose you see on the label is the dose you are getting.
Drug Interaction Databases: What They Report
The Natural Medicines Comprehensive Database rates the lion's mane and amlodipine combination as having "insufficient evidence" for interaction assessment, reflecting the absence of clinical trials rather than a clean safety signal [15]. The Lexicomp drug interaction module (used by most hospital pharmacies) does not flag a specific lion's mane-amlodipine interaction as of 2025, but it carries a general note on antiplatelet activity for H. Erinaceus [15].
Neither "insufficient evidence" nor "no flag" means the combination is definitively safe. It means the data to make a confident statement do not yet exist.
Summary of Interaction Risk by Patient Profile
Different patients carry different levels of risk. A 55-year-old with stage 1 hypertension on amlodipine 5 mg and no other medications faces a genuinely low risk from 500 mg of lion's mane daily. A 70-year-old post-MI patient on amlodipine 10 mg plus aspirin 81 mg plus atorvastatin, with a baseline systolic BP of 108 mmHg, faces a meaningfully different risk profile.
The clinical rule is simple: the more cardiovascular medications already in the regimen, the more important physician review becomes before adding any supplement with vasodilatory or antiplatelet properties.
Frequently asked questions
›Can I take lion's mane while on amlodipine?
›Does lion's mane interact with amlodipine?
›Is lion's mane safe with amlodipine?
›Can lion's mane lower blood pressure further when I am already on amlodipine?
›Does lion's mane affect CYP3A4, the enzyme that metabolizes amlodipine?
›Should I take lion's mane and amlodipine at different times of day?
›Can lion's mane cause bleeding if I also take aspirin with my amlodipine?
›What dose of lion's mane is studied for cognitive benefits?
›Does lion's mane raise or lower blood pressure on its own?
›What should I watch for after starting lion's mane while on amlodipine?
›Are there lion's mane products that are safer to use with amlodipine?
›Should I tell my cardiologist I am taking lion's mane?
References
- FDA. Amlodipine besylate prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/019787s040lbl.pdf
- Nissen SE, Tuzcu EM, Libby P, et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study. JAMA. 2004;292(18):2217-2226. https://jamanetwork.com/journals/jama/fullarticle/199636
- Seden K, Dickinson L, Khoo S, Back D. Grapefruit-drug interactions. Drugs. 2010;70(18):2373-2407. https://pubmed.ncbi.nlm.nih.gov/21142260/
- Nissen SE, Tuzcu EM, Libby P, et al. CAMELOT Investigators. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure. JAMA. 2004;292(18):2217-2226. https://pubmed.ncbi.nlm.nih.gov/15536108/
- Mori K, Inatomi S, Ouchi K, Azumi Y, Tuchida T. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytother Res. 2009;23(3):367-372. https://pubmed.ncbi.nlm.nih.gov/18844328/
- Mori K, Inatomi S, Ouchi K, Azumi Y, Tuchida T. Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment. Phytother Res. 2009;23(3):367-372. https://pubmed.ncbi.nlm.nih.gov/18844328/
- Docherty S, Doughty FL, Smith EF. The Acute and Chronic Effects of Lion's Mane Mushroom Supplementation on Cognitive Function, Stress and Mood in Young Adults: A Double-Blind, Parallel Groups, Pilot Study. Nutrients. 2023;15(22):4842. https://pubmed.ncbi.nlm.nih.gov/38004235/
- Yaoita Y, Danbara K, Kikuchi M. Two new aromatic compounds from Hericium erinaceum. Chem Pharm Bull. 2005;53(8):1202-1203. https://pubmed.ncbi.nlm.nih.gov/16079539/ See also: Wang M, Gao Y, Xu D, Gao Q. A polysaccharide from cultured mycelium of Hericium erinaceus and its anti-gastric ulcer activity. Int J Biol Macromol. 2015;74:41-45. https://pubmed.ncbi.nlm.nih.gov/25479469/
- Mori K, Obara Y, Moriya T, Inatomi S, Nakahata N. Effects of Hericium erinaceus on amyloid beta (25-35) peptide-induced learning and memory deficits in mice. Biomed Res. 2011;32(1):67-72. https://pubmed.ncbi.nlm.nih.gov/21383512/
- Diling C, Chaoqun Z, Jian Y, et al. Immunomodulatory activities of a fungal protein extracted from Hericium erinaceus through regulating the gut microbiota. Front Immunol. 2017;8:666. https://pubmed.ncbi.nlm.nih.gov/28713364/
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. J Am Coll Cardiol. 2018;71(19):e127-e248. https://pubmed.ncbi.nlm.nih.gov/29146535/
- Yi Z, Shao-Long Y, Ai-Hong W, et al. Protective effect of ethanol extracts of Hericium erinaceus on alloxan-induced diabetic neuropathic pain in rats. Evid Based Complement Alternat Med. 2015;2015:595480. https://pubmed.ncbi.nlm.nih.gov/26366174/
- Iadecola C, Yaffe K, Biller J, et al. Impact of Hypertension on Cognitive Function: A Scientific Statement From the American Heart Association. Hypertension. 2016;68(6):e67-e94. https://pubmed.ncbi.nlm.nih.gov/27977393/
- Bak WC, Park JH, Park YA, Ka KH. Determination of glucan contents in the fruiting bodies and mycelia of Lentinula edodes cultivars. Mycobiology. 2014;42(4):301-307. https://pubmed.ncbi.nlm.nih.gov/25606013/
- Ulbricht C, Weissner W, Basch E, et al. Maitake mushroom (Grifola frondosa): systematic review by the Natural Standard Research Collaboration. J Soc Integr Oncol. 2009;7(2):66-72. https://pubmed.ncbi.nlm.nih.gov/19476741/